[Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
Czerwenka
K F
KF
I. Univers.-Frauenklinik Wien.
Zeillinger
R
R
Kury
F
F
Manavi
M
M
Speiser
P
P
Peschke
M
M
Steinhart
U
U
Hosmann
J W
JW
Kubista
E
E
D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000235:genetics* / Q000473:pathology*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D005784:Gene Amplification / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D009361:Neoplasm Invasiveness; D009376:Neoplasms, Hormone-Dependent / Q000235:genetics* / Q000473:pathology*; D016133:Polymerase Chain Reaction / Q000379:methods*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen / Q000235:genetics*; D011980:Receptors, Progesterone / Q000235:genetics*
D066246:ErbB Receptors; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
Anwendung der Polymerase-Kettenreaktion (PCR) als Zusatzdiagnostik in der Gynäko-Onkologie.